$DXCM news
The latest DXCM stock news: headlines, filings, AI summaries and sentiment for $DXCM, updated around the clock.
- Senseonics Reports 140% Year-Over-Year Revenue Growth in Q3 2026
- Dexcom Reports Q3 2026 Revenue Growth of 11% Driven by U.S. Market Gains
- Dexcom Projects 2026 Revenue Between $5.20B-$5.25B and Authorizes $1B Share Buyback
- DEXCOM INC - 10-Q Filing
- Shopify and Dexcom Positioned for Growth Through AI Integration
- Dexcom Announces $1 Billion Share Repurchase Program Through 2027
- DEXCOM INC - 8-K Filing
- Oura Files for $2.2 Billion IPO Amid Expansion into Healthcare Features
- Medtronic Raises Fiscal Outlook Amid Strong Heart Device Demand
- DEXCOM INC - 8-K Filing
- DEXCOM INC - 8-K Filing
- Oura Shares Key Financials and Regulatory Developments Ahead of IPO
- Dexcom and Abbott Await Medicare Coverage Expansion for Continuous Glucose Monitors
- Healthcare Sector Earnings: Eight Out of Nine Companies Exceed Expectations
- July Healthcare Sector Performance: Regeneron and DexCom Outshine Peers
- DexCom Reports Strong Second Quarter Performance with Growth and Strategic Expansions
- DexCom Reports Strong Q2 Earnings and Outlines Growth Strategy
- Dexcom Adjusts Full-Year Revenue Outlook Following 13% Growth in Second Quarter
- DexCom Reports Strong Q2 Earnings with Revenue Growth and Margin Expansion
- DEXCOM INC - 10-Q Filing
- DexCom Reports Strong Q2 Earnings and Revenue, Beats Estimates
- DEXCOM INC - 8-K Filing
- Intuit Downgraded While Intuitive Surgical Upgraded by Wall Street Analysts
- DexCom Expands FDA-Cleared Use of Stelo Glucose Biosensor for Children
- Piper Sandler Raises Price Target on DexCom to $88
- Dexcom Expands Nondiabetic CGM Market with Nutrisense Acquisition and Product Redesign
- U.S.-Iran Tensions Rise Amid Market Volatility and Snowflake Gains
- ŌURA Files for IPO Amid Medtech Partnerships and Growth
- DexCom Announces Strong Growth Outlook, Shares Rise
- DexCom Outlines Growth Plan and Shareholder-Friendly Measures
- DexCom Outlines Growth Plan for G8 Launch, Coverage Expansion
- DexCom Reports Strong Q1 Revenue Growth Amid Stock Decline
- DexCom (DXCM) Q1 2026 Earnings Call Transcript
- Dexcom Maintains Full-Year Revenue Forecast After Exceeding Quarterly Estimates
- DexCom Reports Q1 2026 Earnings with Strong Revenue Growth and Improved Margins
- Medtech Companies Increasingly Invest in AI Diagnostics Amid Market Growth